There is one clinical trial.
A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.
genotyping for rs7961953 and additional SNPs in TMTC2 from other linkage disequilibrium patterns.